Helle Odgaard

Helle Odgaard serves as an Overlæge (senior consultant) at Aalborg University Hospital and is academically affiliated with the Faculty of Medicine, Department of Gynaecology and Obstetrics at Aalborg University. Her role integrates clinical practice with research in women's health, focusing on evidence-based interventions for complex gynaecological and obstetric conditions.

Her primary research spans Obstetrics and Gynaecology, with specialized emphasis on Urogynecology (particularly Lichen Sclerosus and Overactive Bladder interrelationships) and Fetal Medicine (specifically Small for Gestational Age screening protocols). The fingerprint data highlights symptom-focused investigations in dermatological-urological comorbidities and fetal growth assessment methodologies, reflecting clinically driven research priorities.

Analysis of her publication trajectory reveals consistent contributions to diagnostic and therapeutic standards: recent work examines lichen sclerosus treatment efficacy on bladder symptoms (2023), while earlier studies establish Danish screening frameworks for fetal growth restriction (2018–2020) and pharmacological management in obstetric diabetes (2016). This progression demonstrates applied research targeting tangible clinical improvements in maternal-fetal medicine.